U.S., Jan. 22 -- ClinicalTrials.gov registry received information related to the study (NCT07355257) titled 'TELITACICEPT IN INFLAMMATORY MYOPATHIES(TELITACICEPT-IM)' on Jan. 19.
Brief Summary: The goal of this clinical trial is to evaluate the efficacy of Telitacicept in the treatment of inflammatory myopathy in patients with inflammatory diseases. The main question it aims to answer is: the safety and effectiveness of Telitacicept in treating inflammatory myopathy.
Study Start Date: Feb. 02
Study Type: INTERVENTIONAL
Condition:
Inflammatory Myopathy
Intervention:
DRUG: Telitacicept 240mg
On the basis of the original foundational medication regimen, add Telitacicept 240mg administered via subcutaneous injection once a week for a to...